Rankings
▼
Calendar
ZYME FY 2021 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena
ZYME
Zymeworks Inc.
$2B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$27M
-31.5% YoY
Gross Profit
$27M
100.0% margin
Operating Income
-$216M
-808.2% margin
Net Income
-$212M
-794.0% margin
EPS (Diluted)
$-4.61
Cash Flow
Operating Cash Flow
-$192M
Free Cash Flow
-$206M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$389M
Total Liabilities
$140M
Stockholders' Equity
$249M
Cash & Equivalents
$202M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$27M
$39M
-31.5%
Gross Profit
$27M
-$132M
+120.2%
Operating Income
-$216M
-$187M
-15.0%
Net Income
-$212M
-$181M
-17.3%
← Q4 2020
All Quarters
Q1 2021 →